Increased platelet serotonin in bipolar depression and hypomania

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Altered serotonin (5-HT) levels are implicated in mood disorders.
• Previous research suggests differences in 5-HT metabolism between unipolar and bipolar depression.

Purpose of the Study:

• To investigate platelet serotonin levels and related parameters in untreated bipolar depressives compared to unipolar depressives and controls.
• To explore the relationship between serotonin levels, uptake, and monoamine oxidase activity in different depressive subtypes.

Main Methods:

• Measurement of platelet serotonin (5-HT) levels in untreated bipolar depressives, unipolar depressives, and healthy controls.
• Analysis of 5-HT uptake into platelets and platelet monoamine oxidase (MAO) activity.
• Longitudinal assessment of 5-HT in a bipolar II patient across different clinical states and during treatment.

Main Results:

• Untreated bipolar depressives exhibited significantly higher morning platelet 5-HT levels compared to controls.
• Unipolar depressives showed normal 5-HT levels but altered diurnal rhythmicity.
• Platelet 5-HT levels were not correlated with 5-HT uptake in bipolar depressives, unlike in unipolar depressives and controls.
• A tendency towards a negative correlation between 5-HT levels and platelet MAO activity was observed in bipolar depressives.
• Platelet 5-HT remained consistently high in a bipolar II patient across depressive and hypomanic states, only decreasing with clomipramine treatment.

Conclusions:

• Platelet serotonin dysregulation, characterized by elevated levels and altered correlations with uptake and MAO activity, may be a key feature distinguishing bipolar depression from unipolar depression.
• Serotonin's role in bipolar illness appears complex and potentially state-independent, with treatment-specific modulation observed.